ViaPlex™ enables fluorescent barcoding of up to 15 cell populations in a single tube to reduce reagent use, save time, and increase throughput for flow cytometry workflows.FREMONT, CA, March 19, 2026 ...

Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...

ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh's Roslin Institute to advance veterinary immunology research ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

A project at the University of Twente has carried out two investigations into the optical properties of human milk. Published ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...

Affinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy and screening. Which strategy is ahead? Let's see.

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.